Jill Gilbert
Vanderbilt University · 159 works · 9,056 citations · h-index 42
Top works
- Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
- Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
- Head and Neck Cancers
- E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
- NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
- NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
- Dysphagia in Head and Neck Cancer Patients Treated With Radiation: Assessment, Sequelae, and Rehabilitation
- Head and Neck Cancers, Version 2.2014
- Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC
- Head and Neck Cancers, Version 1.2015
- Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel
- ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
- Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma
- Head and Neck Cancers, Version 2.2013
- Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group
- Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial
- Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
- Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life
- Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma